In late October we were getting close to field goal
range..
IR reported:
"Now that our pre-BTD has been submitted we await FDA feedback expected some time this week. We are hopeful that they will recommend proceeding on to the BTD application.
.. since then we have reformatted the data as per their request and for all we know BTD is applied for.
"We feel we have satisfied the requests they made in July of last year, therefore in our opinion, we should receive a recommendation to proceed.
Additionally, we feel that our results, in particular our Duration of Response results are very strong and more thorough than our competitors, therefore we feel that we have a good chance of receiving the BTD designation before the end of the year.
Lastly in addition to the BTD submission, we continue to move forward on our primary objectives:
- Completing the enrolment of our clinical study by end of 2024, early next year. We are in the process of adding 5 additional sites to accelerate our enrolment.
- Commencing a strategic partnership. We have several ongoing discussions that continue to develop."
... SEVERAL STRATEGIC PARTNERSHIPS... I wonder which major Pharma's this eludes to?
"Receiving approval for a government program that could assist with our capitalization objective; this decision could come at any time"
Wouldn't want to be on the outside at this moment!.. tick tock ..tick tock ..tick tock
-
- "Securing capital from an institutional investor, Family Office, or large retail investor"
- I for one believe we're close.